FDA Inspection 1052005 — Dhaliwal Labs North, LLC
The FDA completed an inspection of Dhaliwal Labs North, LLC on May 15, 2018 in Bedford Park, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 15, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bedford Park, IL (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1105 | 21 CFR 211.22(d) | Procedures not in writing, fully followed |
| 4368 | 21 CFR 211.188(b)(12) | Investigations made into any unexplained discrepancy |